Visser MR - Search Results

1

[Anglo-Saxon guidelines for the treatment of community-acquired pneumonia applicable in The Netherlands as well].

Hoepelman IM, Sachs AP, Visser MR, Lammers JW. Hoepelman IM, et al. Among authors: visser mr. Ned Tijdschr Geneeskd. 1997 Aug 16;141(33):1597-601. Ned Tijdschr Geneeskd. 1997. PMID: 9543764 Review. Dutch.

2

Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia.

Zeylemaker MM, Jaspers CA, van Kraaij MG, Visser MR, Hoepelman IM. Zeylemaker MM, et al. Among authors: visser mr. Eur J Clin Microbiol Infect Dis. 2001 Jun;20(6):380-4. doi: 10.1007/pl00011278. Eur J Clin Microbiol Infect Dis. 2001. PMID: 11476436

3

Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.

Visser MR, Rozenberg-Arska M, Beumer H, Hoepelman IM, Verhoef J. Visser MR, et al. Antimicrob Agents Chemother. 1991 May;35(5):858-68. doi: 10.1128/AAC.35.5.858. Antimicrob Agents Chemother. 1991. PMID: 1854167 Free PMC article.

4

Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.

Hoepelman IM, Havinga WH, Benne RA, Zwinkels M, de Wit MA, de Hond HA, Boon TA, Visser MR, van Asbeck FW, Verhoef J. Hoepelman IM, et al. Among authors: visser mr. Eur J Clin Microbiol Infect Dis. 1993 May;12(5):343-7. doi: 10.1007/BF01964430. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8394815 Clinical Trial.

5

Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).

Visser MR, Hoepelman IM, Beumer H, Rozenberg-Arska M, Verhoef J. Visser MR, et al. Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1061-4. doi: 10.1007/BF01975170. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2695328

6

[Intra-osseus gas formation in osteomyelitis of vertebrae and pelvis by Klebsiella pneumoniae].

Lewin F, Visser MR, van Vroonhoven TJ, van der Werken C. Lewin F, et al. Among authors: visser mr. Ned Tijdschr Geneeskd. 1999 May 8;143(19):1001-3. Ned Tijdschr Geneeskd. 1999. PMID: 10368722 Dutch.

7

[Reduced risk of complications associated with severe acute (necrotizing) pancreatitis by administration of antibiotics; results from a literature review].

Bosscha K, Vos A, Visser MR, Berger P, van Dullemen H, Ploeg RJ, Gooszen HG. Bosscha K, et al. Among authors: visser mr. Ned Tijdschr Geneeskd. 2001 Oct 13;145(41):1982-5. Ned Tijdschr Geneeskd. 2001. PMID: 11680070 Review. Dutch.

8

Predictors of recurrence of fulminant bacterial peritonitis after discontinuation of antibiotics in open management of the abdomen.

Visser MR, Bosscha K, Olsman J, Vos A, Hulstaert PF, van Vroonhoven TJ, van der Werken C. Visser MR, et al. Eur J Surg. 1998 Nov;164(11):825-9. doi: 10.1080/110241598750005228. Eur J Surg. 1998. PMID: 9845127

9

A decade of experience with selective decontamination of the digestive tract as prophylaxis for infections in patients in the intensive care unit: what have we learned?

Verhoef J, Verhage EA, Visser MR. Verhoef J, et al. Among authors: visser mr. Clin Infect Dis. 1993 Dec;17(6):1047-54. doi: 10.1093/clinids/17.6.1047. Clin Infect Dis. 1993. PMID: 8110929 Review.

10

Infectious disease therapy in the 1990s. Where are we heading?

Rozenberg-Arska M, Visser MR. Rozenberg-Arska M, et al. Among authors: visser mr. Drugs. 1992 May;43(5):629-36. doi: 10.2165/00003495-199243050-00001. Drugs. 1992. PMID: 1379143 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters